World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
94317
World Ranking
2765
National Ranking
1542

Overview

James O. Armitage is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily focuses on the field of Medicine, with substantial contributions to Oncology, Pathology and Forensic Medicine, Cognitive Neuroscience, Hematology, and Pulmonary and Respiratory Medicine.

The scientist has published extensively on topics including Lymphoma Diagnosis and Treatment, Neuroscience and Music Perception, Viral-associated Cancers and Disorders, CAR-T Cell Therapy Research, Acute Myeloid Leukemia Research, Frailty in Older Adults, and Lung Cancer Treatments and Mutations.

James O. Armitage has several recent publications. Notable papers include:

  • Mantle-Cell Lymphoma, 2022, New England Journal of Medicine
  • Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions, 2021, The Lancet Haematology
  • Reaction Time Data in Music Cognition: Comparison of Pilot Data From Lab, Crowdsourced, and Convenience Web Samples, 2020, Frontiers in Psychology
  • Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations, 2020, Blood Reviews
  • Online Data Collection in Auditory Perception and Cognition Research: Recruitment, Testing, Data Quality and Ethical Considerations, 2021, Auditory Perception & Cognition

Frequent co-authors collaborating with James O. Armitage include:

  • Matthew A. Lunning
  • Julie M. Vose
  • Tuomas Eerola
  • R. Gregory Bociek
  • Avyakta Kallam

The main venues where James O. Armitage has published repeatedly are:

  • Blood
  • Hematological Oncology
  • New England Journal of Medicine
  • Frontiers in Psychology
  • Auditory Perception & Cognition

In addition to journal publications, James O. Armitage has contributed to book publications, including a work published by Elsevier BV titled Abeloff's Clinical Oncology in 2020.

Best Publications

  • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

    Ash A. Alizadeh;Michael B. Eisen;R. Eric Davis;Izidore S. Lossos

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

    James O. Armitage;Dennis D. Weisenburger

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Thomas J. Smith;James Khatcheressian;Gary H. Lyman;Howard Ozer

  • 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines*

    Thomas J. Smith;Howard Ozer;Langdon L. Miller;Charles A. Schiffer

  • Non-Hodgkin lymphoma.

    James O Armitage;Randy D Gascoyne;Matthew A Lunning;Franco Cavalli

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

    T. Philip;James Olen Armitage;G. Spitzer;F. Chauvin

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations

    J. R. Anderson;J. O. Armitage;D. D. Weisenburger

  • Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

    Thomas J. Smith;Kari Bohlke;Gary H. Lyman;Kenneth R. Carson

  • Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group

    Jamie K. Waselenko;Thomas J. MacVittie;William F. Blakely;Nicki Pesik

Frequent Co-Authors

Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Dennis D. Weisenburger
Dennis D. Weisenburger University of Nebraska Medical Center
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Wing C. Chan
Wing C. Chan City of Hope
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Jan Delabie
Jan Delabie University Health Network
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Elias Campo
Elias Campo University of Barcelona
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, online degree pathways offer flexible and affordable options. The rise of accredited remote programs makes it easier to specialize or advance your credentials while balancing work or personal commitments.

If you're drawn to healthcare management, consider exploring the cheapest mha online programs. These degrees focus on the business and leadership side of healthcare, preparing graduates for roles in administration, policy, and hospital operations.

Nurses aiming for the highest level of clinical practice can look into a 1 year dnp program online. Accelerated Doctor of Nursing Practice programs are designed for working professionals who want to quickly transition into advanced practice or leadership roles.

Pharmacy is another rewarding avenue. To become a pharmacist, you can investigate the best online pharmacy school choices, combining clinical expertise with pharmacological knowledge.

Lastly, the digital transformation of healthcare means there’s high demand for experts in information systems. Degrees from healthcare informatics degree programs prepare you to analyze data and manage healthcare records—a crucial role in modern medicine.

Best Scientists Citing James O. Armitage

Trending Scientists